BMP9 functions as a negative regulator in the myogenic differentiation of primary mouse myoblasts

Biosci Biotechnol Biochem. 2023 Oct 25;87(11):1255-1264. doi: 10.1093/bbb/zbad104.

Abstract

BMP9, a member of the TGF-β superfamily, reveals the great translational promise for it has been shown to have the strong effect of osteogenic activity in vitro and in vivo. However, the implantation of certain BMPs (bone morphogenetic proteins) into muscular tissues induces ectopic bone formation. BMPs induce osteoblastic differentiation in skeletal muscle, suggesting that myogenic stem cells, such as myoblasts, are the potential progenitors of osteoblasts during heterotopic bone differentiation. Here, we investigate the role of BMP9 during primary mouse myoblasts differentiation. We found BMP9 enhanced cell proliferation and reduced myogenic differentiation of primary mouse myoblasts. In addition, adenovirus-mediated overexpression of BMP9 delayed muscle regeneration after BaCl2-induced injury. ALK1 knockdown reversed the inhibition of myoblast differentiation induced by BMP9. Our data indicate that BMP9 inhibits myogenic differentiation in primary mouse myoblasts and delays skeletal muscle regeneration after injury.

Keywords: BMP9; myoblast; myogenic differentiation; skeletal muscle regeneration.

MeSH terms

  • Animals
  • Bone and Bones*
  • Cell Differentiation
  • Growth Differentiation Factor 2* / metabolism
  • Growth Differentiation Factor 2* / pharmacology
  • Mice
  • Myoblasts / metabolism
  • Osteoblasts / metabolism
  • Osteogenesis

Substances

  • Growth Differentiation Factor 2
  • Gdf2 protein, mouse